1	The	the	_	_	_	_	_	_	_
2	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
3	virus	virus	_	_	_	_	_	_	_
4	oncogene	oncogene	_	_	_	_	_	_	_
5	product	product	_	_	_	_	_	_	_
6	latent	latent	_	_	_	_	_	_	_
7	membrane	membrane	_	_	_	_	_	_	_
8	protein	protein	_	_	_	_	_	_	_
9	1	1	_	_	_	_	_	_	_
10	engages	engage	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	tumor	tumor	_	_	_	_	_	_	_
13	necrosis	necrosis	_	_	_	_	_	_	_
14	factor	factor	_	_	_	_	_	_	_
15	receptor-associated	receptor-associated	_	_	_	_	_	_	_
16	death	death	_	_	_	_	_	_	_
17	domain	domain	_	_	_	_	_	_	_
18	protein	protein	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	mediate	mediate	_	_	_	_	_	_	_
21	B	B	_	_	_	_	_	_	_
22	lymphocyte	lymphocyte	_	_	_	_	_	_	_
23	growth	growth	_	_	_	_	_	_	_
24	transformation	transformation	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	activate	activate	_	_	_	_	_	_	_
27	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
3	virus	virus	_	_	_	_	_	_	_
4	latent	latent	_	_	_	_	_	_	_
5	membrane	membrane	_	_	_	_	_	_	_
6	protein	protein	_	_	_	_	_	_	_
7	1	1	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	LMP1	lmp1	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	essential	essential	_	_	_	_	_	_	_
13	for	for	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	transformation	transformation	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	B	B	_	_	_	_	_	_	_
18	lymphocytes	lymphocyte	_	_	_	_	_	_	_
19	into	into	_	_	_	_	_	_	_
20	lymphoblastoid	lymphoblastoid	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	lines	line	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Previous	previous	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	are	be	_	_	_	_	_	_	_
4	consistent	consistent	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	model	model	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	LMP1	LMP1	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	constitutively	constitutively	_	_	_	_	_	_	_
13	activated	activate	_	_	_	_	_	_	_
14	receptor	receptor	_	_	_	_	_	_	_
15	that	that	_	_	_	_	_	_	_
16	transduces	transduce	_	_	_	_	_	_	_
17	signals	signal	_	_	_	_	_	_	_
18	for	for	_	_	_	_	_	_	_
19	transformation	transformation	_	_	_	_	_	_	_
20	through	through	_	_	_	_	_	_	_
21	its	its	_	_	_	_	_	_	_
22	carboxyl-terminal	carboxyl-terminal	_	_	_	_	_	_	_
23	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
24	tail	tail	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	One	one	_	_	_	_	_	_	_
2	transformation	transformation	_	_	_	_	_	_	_
3	effector	effector	_	_	_	_	_	_	_
4	site	site	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	TES1	TES1	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	located	located	_	_	_	_	_	_	_
10	within	within	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	membrane	membrane	_	_	_	_	_	_	_
13	proximal	proximal	_	_	_	_	_	_	_
14	45	45	_	_	_	_	_	_	_
15	residues	residue	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
19	tail	tail	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	constitutively	constitutively	_	_	_	_	_	_	_
22	engages	engage	_	_	_	_	_	_	_
23	tumor	tumor	_	_	_	_	_	_	_
24	necrosis	necrosis	_	_	_	_	_	_	_
25	factor	factor	_	_	_	_	_	_	_
26	receptor-associated	receptor-associated	_	_	_	_	_	_	_
27	factors	factor	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Signals	signal	_	_	_	_	_	_	_
2	from	from	_	_	_	_	_	_	_
3	TES1	TES1	_	_	_	_	_	_	_
4	are	be	_	_	_	_	_	_	_
5	sufficient	sufficient	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	drive	drive	_	_	_	_	_	_	_
8	initial	initial	_	_	_	_	_	_	_
9	proliferation	proliferation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	infected	infected	_	_	_	_	_	_	_
12	resting	rest	_	_	_	_	_	_	_
13	B	b	_	_	_	_	_	_	_
14	lymphocytes	lymphocyte	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	but	but	_	_	_	_	_	_	_
17	most	most	_	_	_	_	_	_	_
18	lymphoblastoid	lymphoblastoid	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	infected	infect	_	_	_	_	_	_	_
21	with	with	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	virus	virus	_	_	_	_	_	_	_
24	that	that	_	_	_	_	_	_	_
25	does	do	_	_	_	_	_	_	_
26	not	not	_	_	_	_	_	_	_
27	express	express	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	155	155	_	_	_	_	_	_	_
30	residues	residue	_	_	_	_	_	_	_
31	beyond	beyond	_	_	_	_	_	_	_
32	TES1	TES1	_	_	_	_	_	_	_
33	fail	fail	_	_	_	_	_	_	_
34	to	to	_	_	_	_	_	_	_
35	grow	grow	_	_	_	_	_	_	_
36	as	as	_	_	_	_	_	_	_
37	long-term	long-term	_	_	_	_	_	_	_
38	cell	cell	_	_	_	_	_	_	_
39	lines	line	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	now	now	_	_	_	_	_	_	_
3	find	find	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	mutating	mutate	_	_	_	_	_	_	_
6	two	two	_	_	_	_	_	_	_
7	tyrosines	tyrosine	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	isoleucine	isoleucine	_	_	_	_	_	_	_
11	at	at	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	carboxyl	carboxyl	_	_	_	_	_	_	_
14	end	end	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
18	tail	tail	_	_	_	_	_	_	_
19	cripples	cripple	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	ability	ability	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	EBV	EBV	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	cause	cause	_	_	_	_	_	_	_
26	lymphoblastoid	lymphoblastoid	_	_	_	_	_	_	_
27	cell	cell	_	_	_	_	_	_	_
28	outgrowth	outgrowth	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	thereby	thereby	_	_	_	_	_	_	_
31	marking	mark	_	_	_	_	_	_	_
32	a	a	_	_	_	_	_	_	_
33	second	second	_	_	_	_	_	_	_
34	transformation	transformation	_	_	_	_	_	_	_
35	effector	effector	_	_	_	_	_	_	_
36	site	site	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	TES2	TES2	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	yeast	yeast	_	_	_	_	_	_	_
3	two-hybrid	two-hybrid	_	_	_	_	_	_	_
4	screen	screen	_	_	_	_	_	_	_
5	identified	identify	_	_	_	_	_	_	_
6	TES2	tes2	_	_	_	_	_	_	_
7	interacting	interacting	_	_	_	_	_	_	_
8	proteins	protein	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	including	include	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	tumor	tumor	_	_	_	_	_	_	_
13	necrosis	necrosis	_	_	_	_	_	_	_
14	factor	factor	_	_	_	_	_	_	_
15	receptor-associated	receptor-associated	_	_	_	_	_	_	_
16	death	death	_	_	_	_	_	_	_
17	domain	domain	_	_	_	_	_	_	_
18	protein	protein	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	TRADD	TRADD	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	TRADD	TRADD	_	_	_	_	_	_	_
2	was	be	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	only	only	_	_	_	_	_	_	_
5	protein	protein	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	interacted	interact	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	wild-type	wild-type	_	_	_	_	_	_	_
10	TES2	tes2	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	not	not	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	isoleucine-mutated	isoleucine-mutated	_	_	_	_	_	_	_
15	TES2	tes2	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	TRADD	TRADD	_	_	_	_	_	_	_
2	associated	associate	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	wild-type	wild-type	_	_	_	_	_	_	_
5	LMP1	lmp1	_	_	_	_	_	_	_
6	but	but	_	_	_	_	_	_	_
7	not	not	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	isoleucine-mutated	isoleucine-mutated	_	_	_	_	_	_	_
10	LMP1	lmp1	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	mammalian	mammalian	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	TRADD	tradd	_	_	_	_	_	_	_
17	constitutively	constitutively	_	_	_	_	_	_	_
18	associated	associate	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	LMP1	lmp1	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	EBV-transformed	ebv-transformed	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	transfection	transfection	_	_	_	_	_	_	_
3	assays	assay	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	TRADD	TRADD	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	TES2	TES2	_	_	_	_	_	_	_
8	synergistically	synergistically	_	_	_	_	_	_	_
9	mediated	mediate	_	_	_	_	_	_	_
10	high-level	high-level	_	_	_	_	_	_	_
11	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	LMP1	lmp1	_	_	_	_	_	_	_
6	appropriates	appropriate	_	_	_	_	_	_	_
7	TRADD	tradd	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	enable	enable	_	_	_	_	_	_	_
10	efficient	efficient	_	_	_	_	_	_	_
11	long-term	long-term	_	_	_	_	_	_	_
12	lymphoblastoid	lymphoblastoid	_	_	_	_	_	_	_
13	cell	cell	_	_	_	_	_	_	_
14	outgrowth	outgrowth	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	High-level	high-level	_	_	_	_	_	_	_
2	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	also	also	_	_	_	_	_	_	_
5	appears	appear	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	be	be	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	critical	critical	_	_	_	_	_	_	_
10	component	component	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	long-term	long-term	_	_	_	_	_	_	_
13	outgrowth	outgrowth	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

